Listen Here Market Institute President Charles Sauer joined Lars Larson on “The Lars Larson Show” to discuss why Alzheimer’s policy could become a defining issue in the upcoming election cycle — especially in key swing states. The conversation focused on new polling data, early diagnosis, access to treatment, and the Read more…
A new op-ed by Charles Sauer in the Washington Examiner argues that Republicans have a major political opportunity to connect with seniors, independents, and swing voters by leading on Alzheimer’s prevention, early diagnosis, and expanded access to treatment. Drawing on new polling from the Market Institute conducted by Fabrizio Ward, Read more…
Supermajority of Voters Favor Candidates Who Support Coverage for Early Diagnosis and Treatment (WASHINGTON, D.C. – May 19, 2026) A new national survey released by the Market Institute ahead of the midterms shows that a supermajority of voters – including independents and those in key swing states – want candidates Read more…
Alzheimer’s disease is becoming one of the defining health care challenges facing American families. New polling conducted by Fabrizio Ward shows overwhelming bipartisan support for improving access to early Alzheimer’s detection, diagnosis, and treatment through Medicare and private insurance coverage. The survey of voters nationwide — including key battleground states Read more…
A new op-ed by Charles Sauer in the Washington Times argues that earlier Alzheimer’s diagnosis is not only a healthcare issue, but also a financial one for millions of American families. In the piece, Sauer explains how cognitive decline often begins affecting financial decision-making years before a formal diagnosis, leaving Read more…
In a recent piece for the Daily Caller, Charles Sauer highlights a growing disconnect between medical innovation and public policy when it comes to Alzheimer’s care—and the consequences could not be more serious. Health and Human Services Secretary Robert F. Kennedy Jr. recently put it plainly: “it is regulatory malpractice Read more…
Healthcare is intensely personal, especially when devastating diagnoses arrive. Yet too often, a system weighed down by regulation and bureaucracy compounds that pain, forcing patients and families to navigate life-altering decisions without the support or flexibility they need. In a recent piece published on The Capitalist Substack, Market Institute President Read more…
In a powerful Wall Street Journal essay, retired internal-medicine physician Brent Beasley recounts how he discovered—almost by accident—that he had Alzheimer’s disease at age 57. His story is not just personal. It is an indictment of a U.S. health care system that waits for crisis instead of preventing it. Beasley Read more…
This month, the Alzheimer’s Policy Working Group (APWG) released a new policy paper, Solving America’s Alzheimer’s Challenge, laying out a clinician-driven roadmap to improve how the U.S. diagnoses and manages Alzheimer’s disease—starting in primary care, where most patients first raise concerns. The paper reflects the real-world experience of frontline physicians Read more…
Alzheimer’s disease is no longer just a medical challenge. It is a looming fiscal crisis—and one the United States is dangerously unprepared to confront. In a recent column published in The Capitalist, Charles Sauer argued that policymakers urgently need to recognize Alzheimer’s as an economic ticking time bomb. Without a Read more…